271 related articles for article (PubMed ID: 14649881)
21. Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.
Muro K; Das S; Raizer JJ
Technol Cancer Res Treat; 2006 Jun; 5(3):201-13. PubMed ID: 16700617
[TBL] [Abstract][Full Text] [Related]
22. Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma.
Zhu X; Zhou H; Liu Y; Wen Y; Wei C; Yu Q; Liu J
Acta Biomater; 2018 Dec; 82():143-157. PubMed ID: 30316026
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
24. Immunotoxin treatment of brain tumors.
Hall WA
Methods Mol Biol; 2001; 166():139-54. PubMed ID: 11217364
[No Abstract] [Full Text] [Related]
25. Local treatment of brain tumors with targeted chimera cytotoxic proteins.
Debinski W
Cancer Invest; 2002; 20(5-6):801-9. PubMed ID: 12197239
[TBL] [Abstract][Full Text] [Related]
26. Convection-enhanced delivery of targeted toxins for malignant glioma.
Hall WA; Sherr GT
Expert Opin Drug Deliv; 2006 May; 3(3):371-7. PubMed ID: 16640497
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
[TBL] [Abstract][Full Text] [Related]
28. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
29. Targeted toxin therapy for malignant astrocytoma.
Hall WA
Neurosurgery; 2000 Mar; 46(3):544-51; discussion 552. PubMed ID: 10719849
[TBL] [Abstract][Full Text] [Related]
30. Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.
Jain A; Jain A; Garg NK; Tyagi RK; Singh B; Katare OP; Webster TJ; Soni V
Acta Biomater; 2015 Sep; 24():140-51. PubMed ID: 26116986
[TBL] [Abstract][Full Text] [Related]
31. Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor.
McGraw TE; Greenfield L; Maxfield FR
J Cell Biol; 1987 Jul; 105(1):207-14. PubMed ID: 3611186
[TBL] [Abstract][Full Text] [Related]
32. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
[TBL] [Abstract][Full Text] [Related]
33. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.
Kawakami M; Kawakami K; Puri RK
J Neurooncol; 2003 Oct; 65(1):15-25. PubMed ID: 14649882
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
36. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
37. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
38. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems.
Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C
Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442
[TBL] [Abstract][Full Text] [Related]
39. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract][Full Text] [Related]
40. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
